#kidney

The science behind Truvada as pre-exposure prophylaxis reveals an awesome tool that is apparently already helping shrink U.S. HIV rates.

Highlights from research presented at the 52nd International Liver Congress in Amsterdam

Also, among those with both viruses, a failed hep C cure attempt is associated with a lower risk of diabetes compared with a successful one.

The cohort study also found that older individuals on PrEP were at greater risk of reduced kidney function.

Sovaldi, included in Harvoni and Epclusa, may affect a key liver enzyme that activates the HIV drug Viread.

HIV-positive people 50 and older who switched from Truvada to Descovy in a recent trial reaped health benefits.

Taking care of your whole health is just as important as taking care of your HIV.

A new analysis suggests that more frequent safety monitoring may be advisable for older people taking Truvada for HIV prevention.

Gilead Sciences has released results from three studies examining the effects of switching from the old tenofovir to the new version.

Researchers call for greater heart disease monitoring and prevention in those with low kidney function.

The FDA has approved Gilead Sciences’ fixed-dose combination tablet Descovy (emtricitabine/tenofovir alafenamide) for HIV treatment.

About 1,000 lives could be saved each year now that people with HIV are allowed to donate organs to others with HIV.

Frequent injection of cocaine raises the risk of chronic kidney impairment among people coinfected with HIV and hepatitis C.

A comparison between the single-tablet HIV med Stribild with a new version of the tablet that includes a revised form of tenofovir has...

An updated version of Viread (tenofovir) offers slightly better viral suppression and improves indicators of kidney and bone health...